BOZEMAN, MT — BioScience Laboratories announces the capability of product efficacy testing versus murine (mouse) norovirus (MNV), a surrogate for human norovirus, according to a press release.
Human noroviruses are estimated to be responsible for over 90 percent of non-bacterial epidemic gastroenteritis worldwide, the release stated.
According to the release, it is not possible to grow human norovirus in cell culture and, as a result, in 2005 the U.S. Environmental Protection Agency (EPA) approved the use of feline calicivirus as a viral surrogate for human norovirus.
However, many scientists believe that MNV, which is genetically and phenotypically similar to human norovirus, is a better surrogate for efficacy testing, the release noted.
BioScience Laboratories has recently added this virus to its virology laboratory and can test for product efficacy against MNV, the new surrogate of choice, the release added.
Click here to read the complete release.